MediWound Ltd. (MDWD) Balance Sheet

The reduction in total assets appears to reflect ongoing cash depletion rather than a deliberate restructuring, since retained earnings remain deeply negative at -$239.3M in 2026Q2. Investors should monitor whether the asset base stabilizes or continues to erode as operating burn persists.

The current ratio remains above 2.0, which suggests short-term obligations are covered on a reported basis, yet the sharp cash drawdown implies the buffer against further operating losses is limited. The quarter-to-quarter volatility in cash balances warrants further investigation into the timing and sources of funding inflows.

Low reported leverage may reflect limited access to debt markets or a deliberate preference for non-debt funding, though the data alone does not establish which. Because debt is small relative to total liabilities of $36.2M, the liability base appears driven more by operating obligations than by borrowings.

The disappearance of deferred revenue is consistent with the contracting top line noted in the income statement analysis and suggests limited pre-billed visibility into future periods. This absence should be weighed against any contracted commitments disclosed outside the supplied data.